Literature DB >> 8092993

Molecular cloning of a novel N-terminal variant of annexin II from rat basophilic leukaemia cells.

A L Upton1, S E Moss.   

Abstract

Rat annexin II cDNA clones were isolated from a rat basophilic leukaemia cell plasmid library by cross-species hybridization with a mouse probe, and fully sequenced using the dideoxy-chain-termination method. Alignment of the derived amino-acid sequence with those of other mammalian annexin II species revealed a high level of conservation, characteristic of the annexin family of proteins. One of the cDNAs isolated contained an additional six nucleotides close to the N-terminus, lying in-frame and at a point corresponding to an intron/exon boundary in the human annexin II gene. As the two rat cDNAs were identical apart from the six nucleotide insert, it is likely that these represent alternatively spliced transcripts of a single gene, rather than the products of two separate genes. The six nucleotides encode serine-glutamine and therefore introduce an additional potential phosphorylation site into a region already containing one tyrosine and two serine phosphorylation sites. The discovery of this novel annexin II variant may have important implications both for p11 binding and for regulation of annexin II function by phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092993      PMCID: PMC1137245          DOI: 10.1042/bj3020425

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  A role for calpactin in calcium-dependent exocytosis in adrenal chromaffin cells.

Authors:  S M Ali; M J Geisow; R D Burgoyne
Journal:  Nature       Date:  1989-07-27       Impact factor: 49.962

2.  Alternative splicing gives rise to two forms of the p68 Ca2(+)-binding protein.

Authors:  S E Moss; M J Crumpton
Journal:  FEBS Lett       Date:  1990-02-26       Impact factor: 4.124

3.  Regulation of calpactin I phospholipid binding by calpactin I light-chain binding and phosphorylation by p60v-src.

Authors:  M A Powell; J R Glenney
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

4.  Aggregation of chromaffin granules by calpactin at micromolar levels of calcium.

Authors:  D S Drust; C E Creutz
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

Review 5.  Ca2+-dependent phospholipid- (and membrane-) binding proteins.

Authors:  C B Klee
Journal:  Biochemistry       Date:  1988-09-06       Impact factor: 3.162

6.  Identity of inositol 1,2-cyclic phosphate 2-phosphohydrolase with lipocortin III.

Authors:  T S Ross; J F Tait; P W Majerus
Journal:  Science       Date:  1990-05-04       Impact factor: 47.728

7.  Structure and chromosome assignment of the murine p36 (calpactin I heavy chain) gene.

Authors:  P Amiguet; P D'Eustachio; T Kristensen; R A Wetsel; C J Saris; T Hunter; D D Chaplin; B F Tack
Journal:  Biochemistry       Date:  1990-02-06       Impact factor: 3.162

8.  Conformational change and localization of calpactin I complex involved in exocytosis as revealed by quick-freeze, deep-etch electron microscopy and immunocytochemistry.

Authors:  T Nakata; K Sobue; N Hirokawa
Journal:  J Cell Biol       Date:  1990-01       Impact factor: 10.539

9.  A prolactin-inducible gene product which is a member of the calpactin/lipocortin family.

Authors:  N D Horseman
Journal:  Mol Endocrinol       Date:  1989-05

10.  Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family.

Authors:  J F Tait; M Sakata; B A McMullen; C H Miao; T Funakoshi; L E Hendrickson; K Fujikawa
Journal:  Biochemistry       Date:  1988-08-23       Impact factor: 3.162

View more
  2 in total

Review 1.  Functional and genetic analysis of annexin VI.

Authors:  H C Edwards; S E Moss
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

2.  Annexin A2 heterotetramer: structure and function.

Authors:  Alamelu Bharadwaj; Moamen Bydoun; Ryan Holloway; David Waisman
Journal:  Int J Mol Sci       Date:  2013-03-19       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.